Background The 2025 British Thoracic Society (BTS) Winter Meeting delivered 3 days of cutting-edge science, clinical innovation and networking in wintry Westminster. Over 2500 attendees from 36 countries gathered to share advances shaping the future of respiratory medicine. Content The programme opened with a session focused on emerging clinical trial data, showcasing pragmatic and mechanistic studies designed to address real-world challenges in respiratory care, setting the tone for a meeting focused on impact and innovation. Translational research featured strongly throughout the meeting, with organoids, precision-cut lung slices and air-liquid interface cultures providing new perspectives on disease mechanisms and therapeutic targets. Early career investigators presented discoveries in eosinophilic chronic obstructive pulmonary disease biology, microbiome-driven viral susceptibility and resistance risks in novel bronchiectasis therapies, while midcareer leaders advanced understanding of familial interstitial lung disease and virus–host interactions. Plenary sessions tackled pressing challenges, from air pollution and breathlessness diagnostics to genetic drivers of pulmonary hypertension, complemented by guest lectures on immune regulation, vaccine-preventable illness and drug discovery. Additionally, the meeting highlighted workforce transformation, emphasising the role of nurses, allied health professionals and pharmacists in delivering integrated, digitally enabled care. Conclusion Reminding us that progress rests on both scientific endeavour and enduring professional bonds, the 2025 BTS Winter Meeting reaffirmed that respiratory research is for everyone—an essential driver of advancement across disciplines. Multidisciplinary working and inclusive engagement will be key to shaping future care and ensuring that innovation translates into better outcomes for patients worldwide.
Flynn et al. (2026) studied this question.